T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma

International Journal of Oncology

Volumn 41, Issue 6, 2012, Pages 1985-1995

  Imajyo, Ikumi ^a   Sugiura, Tsuyoshi ^a   Kobayashi, Yosuke ^a   Shimoda, Miyuki ^a   Ishii, Kotaro ^a   Akimoto, Naonari ^a   Yoshihama, Naoya ^a   Kobayashi, Ieyoshi ^a   Mori, Yoshihide ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Brachyury; Epithelial mesenchymal transition; Lymph nodes; Metastasis; Squamous cell carcinoma

Indexed keywords

T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR BRACHYURY; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CELL ADHESION; COHORT ANALYSIS; CONTROLLED STUDY; DISTANT METASTASIS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; ORAL BIOPSY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, SQUAMOUS CELL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FETAL PROTEINS; GENE EXPRESSION; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; PROTEIN TRANSPORT; T-BOX DOMAIN PROTEINS; VIMENTIN;

EID: 84869838257     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1673     Document Type: Article

References (38)

1. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119: 1438-1449, 2009.
2. Kalluri R: EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 119: 1417-1419, 2009.
3. Otsuki S, Inokuchi M, Enjoji M, et al: Vimentin expression is associated with decreased survival in gastric cancer. Oncol Rep 25: 1235-1242, 2011.
4. Kevans D, Wang LM, Sheahan K, et al: Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status. Int J Surg Pathol 19: 751-760, 2011.
5. Soini Y, Tuhkanen H, Sironen R, et al: Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer 11: 73, 2011.
6. van Nes JG, de Kruijf EM, Putter H, et al: Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients. Breast Cancer Res Treat 133: 49-59, 2011.
7. Sasaki K, Natsugoe S, Ishigami S, et al: Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 28: 158, 2009.
8. Nakashima H, Hashimoto N, Aoyama D, et al: Involvement of the transcription factor twist in phenotype alteration through epithelial- mesenchymal transition in lung cancer cells. Mol Carcinog 51: 400-410, 2011.
9. Yoshida S, Furukawa N, Haruta S, et al: Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: a review. Int J Gynecol Cancer 19: 992-997, 2009.
10. Yang TL, Wu CT, Ko JY, Wang CP, Lou PJ and Chang YL: Significance of tumor satellite variables in reflecting the epithelial-mesenchymal transition of tongue cancer. Oral Oncol 47: 720-724, 2011.
11. Wang C, Liu X, Huang H, et al: Deregulation of Snai2 is associated with metastasis and poor prognosis in tongue squamous cell carcinoma. Int J Cancer 130: 2249-2258, 2011.
12. Sakamoto K, Imanishi Y, Tomita T, et al: Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy. Ann Surg Oncol 19: 612-619, 2011.
13. Dang H, Ding W, Emerson D and Rountree CB: Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics. BMC Cancer 11: 396, 2011.
14. Kojc N, Zidar N, Gale N, et al: Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck. Virchows Arch 454: 549-555, 2009.
15. Taube JH, Herschkowitz JI, Komurov K, et al: Core epithelial-to- mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 107: 15449-15454, 2011.
16. Yang MH, Hsu DS, Wang HW, et al: Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 12: 982-992, 2011.
17. Karreth F and Tuveson DA: Twist induces an epithelial-mesenchymal transition to facilitate tumor metastasis. Cancer Biol Ther 3: 1058-1059, 2004. (Pubitemid 41350984)
18. Kispert A, Herrmann BG, Leptin M and Reuter R: Homologs of the mouse Brachyury gene are involved in the specification of posterior terminal structures in Drosophila, Tribolium, and Locusta. Genes Dev 8: 2137-2150, 1994. (Pubitemid 24300090)
19. Vidricaire G, Jardine K and McBurney MW: Expression of the Brachyury gene during mesoderm development in differentiating embryonal carcinoma cell cultures. Development 120: 115-122, 1994. (Pubitemid 24031193)
20. Fernando RI, Litzinger M, Trono P, Hamilton DH, Schlom J and Palena C: The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J Clin Invest 120: 533-544, 2010.
21. UICC: TNM Classification of Malignant Tumours. 7th edition. Wiley-Liss, New York, NY, 2009.
22. Wasi PN, Cohen B, Luthra UK and Torloni H: Histological typing of oral and oropharyngeal tumors. In: WHO: International Histological Classification of Tumors. WHO Press, Geneva, 1997.
23. Anneroth G, Batsakis J and Luna M: Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 95: 229-249, 1987.
24. Katoh M: Epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol 27: 1677-1683, 2005.
25. Schmalhofer O, Brabletz S and Brabletz T: E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28: 151-166, 2009.
26. Giehl K and Menke A: Microenvironmental regulation of E-cadherin-mediated adherens junctions. Front Biosci 13: 3975-3985, 2008. (Pubitemid 351594675)
27. Satelli A and Li S: Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68: 3033-3046, 2011.
28. Vuoriluoto K, Haugen H, Kiviluoto S, et al: Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30: 1436-1448, 2011.
29. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001. (Pubitemid 33041634)
30. Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746, 2003.
31. Mani SA, Guo W, Liao MJ, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008. (Pubitemid 351636299)
32. Blick T, Hugo H, Widodo E, et al: Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia 15: 235-252, 2010.
33. Du L, Yang Y, Xiao X, et al: Sox2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma. Oral Oncol 47: 709-713, 2011.
34. Episkopou V: SOX2 functions in adult neural stem cells. Trends Neurosci 28: 219-221, 2005.
35. Fernando RI, Castillo MD, Litzinger M, Hamilton DH and Palena C: IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res 71: 5296-5306, 2011.
36. Sarkar D, Shields B, Davies ML, Muller J and Wakeman JA: Brachyury confers cancer stem cell characteristics on colorectal cancer cells. Int J Cancer 130: 328-337, 2012.
37. Ahmed N, Abubaker K, Findlay J and Quinn M: Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets 10: 268-278, 2010.
38. Alison MR, Lim SM and Nicholson LJ: Cancer stem cells: problems for therapy? J Pathol 223: 147-161, 2011.